evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract
18315,GENE_SUMMARY,,PLCG2 encodes an enzyme involved in transmembrane signaling. Mutations of PLCG2 are associated with autoimmunity and immune dysregulation and resistance to Ibrutinib therapy in patients with CLL.,,2017-01-17,,5336,PLCG2,phospholipase C gamma 2,False,ENST00000359376,NM_002661.3,PLC-IV,PLC-gamma-2,APLAID,FCAS3,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18316,GENE_BACKGROUND,,"PLCG2 encodes for the gene phospholipase C gamma 2, a calcium dependent enzyme that cleaves phospholipids (phosphatidylinositol 4,5-bisphosphate (PIP2)) into diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP3) (PMID:20870410). The enzyme is autoinhibited by a C-terminal SH2 domain and activated by phosphorylation (PMID:20807769). It is expressed mainly in B-cells and Natural Killer cells where it acts to transduce signals from the immunglobulin family of receptors (PMID:10933392, 16002670). It is also involved in regulating osteoclast development (PMID:17053833). Mutations and deletions have been associated with autoimmunity and immune dysregulation (PMID:22236196, 23000145). Mutations in PLCG2 are found as resistance mechanisms to Ibruitinib therapy in CLL patients (PMID:24869598). These activating mutations result in Btk independent signaling from the B-cell receptor (PMID:25972157). Polymorphisms in PLCG2 have also been associated with cancer development risk (PMID:24080446, 23874846)",,2017-01-17,,5336,PLCG2,phospholipase C gamma 2,False,ENST00000359376,NM_002661.3,PLC-IV,PLC-gamma-2,APLAID,FCAS3,False,25972157,"Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation.",Blood,2018-07-02T20:15:00,126,True,1961-08-01,Liu TM et al,doi: 10.1182/blood-2015-02-626846,,0001-07-02,,24869598,Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.,The New England journal of medicine,2018-06-12T20:14:00,370,24,2286-94,Woyach JA et al,doi: 10.1056/NEJMoa1400029,,0001-06-12,,22236196,"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions.",The New England journal of medicine,2018-01-26T20:12:00,366,4,330-8,Ombrello MJ et al,doi: 10.1056/NEJMoa1102140,,0001-01-26,,23000145,"A hypermorphic missense mutation in PLCG2, encoding phospholipase Cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiency.",American journal of human genetics,2018-10-05T20:12:00,91,4,713-20,Zhou Q et al,doi: 10.1016/j.ajhg.2012.08.006,,0001-10-05,,24080446,Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.,Endocrine-related cancer,2017-12-01T20:13:00,20,6,875-87,Rudolph A et al,doi: 10.1530/ERC-13-0349,,0001-12-01,,20870410,PLC regulation: emerging pictures for molecular mechanisms.,Trends in biochemical sciences,2018-02-01T20:11:00,36,2,88-96,Bunney TD et al,doi: 10.1016/j.tibs.2010.08.003,,0001-02-01,,10933392,Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors.,Immunity,2018-07-01T20:00:00,13,True,25-35,Wang D et al,,,0001-07-01,,16002670,Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.,"Journal of immunology (Baltimore, Md. : 1950)",2018-07-15T20:05:00,175,2,749-54,Tassi I et al,,,2018-07-15T19:50:00,,23874846,Genetic variants in epidermal growth factor receptor pathway genes and risk of esophageal squamous cell carcinoma and gastric cancer in a Chinese population.,PloS one,2013,8,7,e68999,Li WQ et al,doi: 10.1371/journal.pone.0068999,,Li WQ et al. PloS one. 2013;8(7)e68999.,,20807769,Mechanism of phosphorylation-induced activation of phospholipase C-gamma isozymes.,The Journal of biological chemistry,2018-11-12T20:10:00,285,46,35836-47,Gresset A et al,doi: 10.1074/jbc.M110.166512,,0001-11-12,,17053833,PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.,The Journal of clinical investigation,2018-11-01T20:06:00,116,11,2869-79,Mao D et al,,,0001-11-01,
